Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Biochemical and Biophysical Research Communications
|
December 6, 2022
A pilot study assessing sphingolipids and glycolipids dysmetabolism in idiopathic normal pressure hydrocephalus
Tatsuro Mutoh, Yoshiki Niimi, Shinji Ito, et al.
Journal of Medical Internet Research
|
July 22, 2021
Efficacy and Cost-effectiveness of Promotion Methods to Recruit Participants to an Online Screening Registry for Alzheimer Disease Prevention Trials: Observational Study
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD
|
April 21, 2026
Early adoption of lecanemab in Japan (December 2023-December 2024): Pretreatment diagnostic timelines from the DeSC claims database
Saki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
Biochemical and Biophysical Research Communications
|
December 28, 2020
Galabiosylceramide is present in human cerebrospinal fluid
Hisako Akiyama, Mitsuko Ide, Toshiyuki Yamaji, et al.
Molecular and Cellular Biochemistry
|
July 22, 2025
Cerebrospinal fluid sphingolipid and sterol metabolite profiles of neurologically normal subjects
Yoshiki Niimi, Akihiro Ueda, Hisako Akiyama, et al.
Journal of Parkinson'S Disease
|
November 20, 2020
Cerebrospinal Fluid Profiles in Parkinson's Disease: No Accumulation of Glucosylceramide, but Significant Downregulation of Active Complement C5 Fragment
Yoshiki Niimi, Yasuaki Mizutani, Hisako Akiyama, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
SWI and T2*-GRE Microhemorrhage Counts in Anti-Amyloid Therapy Eligibility: A Real-World-Calibrated Simulation Study
Kenichiro Sato, Ryoko Ihara, Masanori Kurihara, et al.
Neurology
|
December 10, 2013
Anti-neutral glycolipid antibodies in encephalomyeloradiculoneuropathy
Sayuri Shima, Naoki Kawamura, Tomomasa Ishikawa, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
April 16, 2008
MM2-cortical-type sporadic Creutzfeldt-Jakob disease with early stage cerebral cortical pathology presenting with a rapidly progressive clinical course
Yoshiki Niimi, Yasushi Iwasaki, Toshitaka Umemura, et al.
Molecular and Cellular Neurosciences
|
March 31, 2018
Anti-GM1 ganglioside antibodies modulate membrane-associated sphingomyelin metabolism by altering neutral sphingomyelinase activity
Akihiro Ueda, Sayuri Shima, Kenitiroh Murate, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Biochemical and Biophysical Research Communications
|
December 6, 2022
A pilot study assessing sphingolipids and glycolipids dysmetabolism in idiopathic normal pressure hydrocephalus
Tatsuro Mutoh, Yoshiki Niimi, Shinji Ito, et al.
Journal of Medical Internet Research
|
July 22, 2021
Efficacy and Cost-effectiveness of Promotion Methods to Recruit Participants to an Online Screening Registry for Alzheimer Disease Prevention Trials: Observational Study
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD
|
April 21, 2026
Early adoption of lecanemab in Japan (December 2023-December 2024): Pretreatment diagnostic timelines from the DeSC claims database
Saki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
Biochemical and Biophysical Research Communications
|
December 28, 2020
Galabiosylceramide is present in human cerebrospinal fluid
Hisako Akiyama, Mitsuko Ide, Toshiyuki Yamaji, et al.
Molecular and Cellular Biochemistry
|
July 22, 2025
Cerebrospinal fluid sphingolipid and sterol metabolite profiles of neurologically normal subjects
Yoshiki Niimi, Akihiro Ueda, Hisako Akiyama, et al.
Journal of Parkinson'S Disease
|
November 20, 2020
Cerebrospinal Fluid Profiles in Parkinson's Disease: No Accumulation of Glucosylceramide, but Significant Downregulation of Active Complement C5 Fragment
Yoshiki Niimi, Yasuaki Mizutani, Hisako Akiyama, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
SWI and T2*-GRE Microhemorrhage Counts in Anti-Amyloid Therapy Eligibility: A Real-World-Calibrated Simulation Study
Kenichiro Sato, Ryoko Ihara, Masanori Kurihara, et al.
Neurology
|
December 10, 2013
Anti-neutral glycolipid antibodies in encephalomyeloradiculoneuropathy
Sayuri Shima, Naoki Kawamura, Tomomasa Ishikawa, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
April 16, 2008
MM2-cortical-type sporadic Creutzfeldt-Jakob disease with early stage cerebral cortical pathology presenting with a rapidly progressive clinical course
Yoshiki Niimi, Yasushi Iwasaki, Toshitaka Umemura, et al.
Molecular and Cellular Neurosciences
|
March 31, 2018
Anti-GM1 ganglioside antibodies modulate membrane-associated sphingomyelin metabolism by altering neutral sphingomyelinase activity
Akihiro Ueda, Sayuri Shima, Kenitiroh Murate, et al.
Page
of 8